Literature DB >> 3383316

Additive effects of dihydralazine during enflurane or isoflurane hypotensive anaesthesia for spinal fusion.

B Bourreli1, M Pinaud, N Passuti, J P Gunst, J C Drouet, J P Remi.   

Abstract

Sixteen patients (13-38 yr) undergoing spinal fusion for scoliosis under controlled hypotension were studied to determine the haemodynamic and neuroendocrine responses to IV dihydralazine (1.0 mg.kg-1) followed by 0.5 and 1 MAC of enflurane or isoflurane. Twenty minutes after dihydralazine administration mean arterial pressure (-20 per cent) and systemic vascular resistance (-50 per cent) decreased, and cardiac index (+57 per cent), heart rate (+37 per cent) and intrapulmonary shunt increased. Plasma renin activity and aldosterone and norepinephrine levels increased. Further decreases in mean arterial pressure and in systemic vascular resistance were observed when 0.5 MAC enflurane or isoflurane were added. With 1 MAC anaesthetic levels a further decrease in mean arterial pressure was observed in both groups, but pressure fell to a lower level with isoflurane than with enflurane (p less than 0.01). The reduction of arterial blood pressure to a level of 50-60 mmHg for three to four hours was easy to control and was free of complications. The preliminary IV administration of dihydralazine allowed a reduced volatile agent concentration which attenuated undesirable haemodynamic effects, in spite of renin and norepinephrine release, and permitted a rapid intraoperative awakening.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3383316     DOI: 10.1007/BF03010617

Source DB:  PubMed          Journal:  Can J Anaesth        ISSN: 0832-610X            Impact factor:   5.063


  30 in total

Review 1.  Renin-angiotensin system: biochemistry and mechanisms of action.

Authors:  M J Peach
Journal:  Physiol Rev       Date:  1977-04       Impact factor: 37.312

2.  Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects.

Authors:  E Haber; T Koerner; L B Page; B Kliman; A Purnode
Journal:  J Clin Endocrinol Metab       Date:  1969-10       Impact factor: 5.958

Review 3.  Enflurane.

Authors:  G W Black
Journal:  Br J Anaesth       Date:  1979-07       Impact factor: 9.166

4.  Adrenergic component of renin release induced by vasodilating antihypertensive drugs in the rat.

Authors:  W A Pettinger; W B Campbell; K Keeton
Journal:  Circ Res       Date:  1973-07       Impact factor: 17.367

5.  Relation of hydralazine plasma concentration to dosage and hypotensive action.

Authors:  R Zacest; J Koch-Weser
Journal:  Clin Pharmacol Ther       Date:  1972 May-Jun       Impact factor: 6.875

6.  Decreased plasma epinephrine concentrations after glucose ingestion in humans.

Authors:  P Trunet; F Lhoste; J C Ansquer; S Kestenbaum; C Sabatier; J P Tillement; M Rapin
Journal:  Metabolism       Date:  1984-02       Impact factor: 8.694

7.  The use of induced hypotension to control bleeding during posterior fusion for scoliosis.

Authors:  N A Malcolm-Smith; M J McMaster
Journal:  J Bone Joint Surg Br       Date:  1983-05

Review 8.  Respiratory and cardiovascular functions in scoliosis and the principles of anesthetic management.

Authors:  E R Kafer
Journal:  Anesthesiology       Date:  1980-04       Impact factor: 7.892

9.  Hydralazine for controlled hypotension during neurosurgical operations.

Authors:  D J James; R F Bedford
Journal:  Anesth Analg       Date:  1982-12       Impact factor: 5.108

10.  Novel double-isotope technique for enzymatic assay of catecholamines, permitting high precision, sensitivity and plasma sample capacity.

Authors:  M J Brown; D A Jenner
Journal:  Clin Sci (Lond)       Date:  1981-11       Impact factor: 6.124

View more
  3 in total

Review 1.  Induced hypotension during anesthesia with special reference to orthognathic surgery.

Authors:  C Rodrigo
Journal:  Anesth Prog       Date:  1995

Review 2.  An overview of blood-sparing techniques used in spine surgery during the perioperative period.

Authors:  Marek Szpalski; Robert Gunzburg; Bernard Sztern
Journal:  Eur Spine J       Date:  2004-06-15       Impact factor: 3.134

Review 3.  DNA Methylation: a New Player in Multiple Sclerosis.

Authors:  Xiang Li; Bing Xiao; Xing-Shu Chen
Journal:  Mol Neurobiol       Date:  2016-06-17       Impact factor: 5.590

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.